Its monday the 24th ofjuly. Welcome to bbc Newsroom Live. The parents of Charlie Gard Return to the High Court Today, with the judge set to consider new evidence from a us neurologist. His parents want to take their terminally ill baby to america for experimental treatment, but doctors at great 0rmond Street Hospital believe it wont work, and say the ii month old should be allowed to die with dignity. We can speak to our news correspondent, helena lee, whos outside the high court. What are we expecting . The case is expected to begin at 2pm this afternoon, in what has become an incredibly complex and emotive case. The peasants will come back to court, but we expect is the judge in this case to examine all the new evidence that has been given over the past week or so. We know that the past week or so. We know that the american neurologist who flew over from the american neurologist who flew Overfrom America met the american neurologist who flew over from america met with great 0rmond St
Jo s Cervical Cancer Trust, which had been essential in encouraging uptake of the HPV vaccine and routine cervical cancer screening tests, closed after two decades due to financial difficulties.
HPV vaccine program tied to big drop in cervical cancers across all socioeconomic strata umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.
Objectives To replicate previous analyses on the effectiveness of the English human papillomavirus (HPV) vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) using 12 additional months of follow-up, and to investigate effectiveness across levels of socioeconomic deprivation.
Design Observational study.
Setting England, UK.
Participants Women aged 20-64 years resident in England between January 2006 and June 2020 including 29 968 with a diagnosis of cervical cancer and 335 228 with a diagnosis of CIN3. In England, HPV vaccination was introduced nationally in 2008 and was offered routinely to girls aged 12-13 years, with catch-up campaigns during 2008-10 targeting older teenagers aged <19 years.
Main outcome measures Incidence of invasive cervical cancer and CIN3.
Results In England, 29 968 women aged 20-64 years received a diagnosis of cervical cancer and 335 228 a diagnosis of CIN3 between 1 January 2006 and 30 June 2